ZIOPTAN 0.0015% EYE DROP

Tafluprost
$8.4919per EA
High Outlier

Strength

.015 mg/mL

Manufacturer

Thea Pharma Inc.

NDC

82584060930

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

4/22/2026

Active Ingredients

TAFLUPROST

Approval Type

New Drug (NDA)

FDA Application

NDA202514

On Market Since

10/28/2022

Pharmacological Classes

Increased Prostaglandin Activity
Prostaglandin Analog
Prostaglandin Receptor Agonists
Prostaglandins

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

+0.0%

1Y

-0.1%

3Y

+8.1%

5Y

N/A

All

+8.1%

Generic Alternatives

Save up to 67%

1 alternative • Same active ingredient